Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Press
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
St. Mary's Chamber
Elk County Sheriff
St. Mary's Area School District
Elk County Catholic School System
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Gilead Sciences
(NQ:
GILD
)
66.42
USD
+0.46 (+0.70%)
Official Closing Price
/ Updated:
7:37 PM EDT, Sep 20, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
9,775,300
Open
65.89
Bid (Size)
66.20 (2)
Ask (Size)
66.45 (1)
Prev. Close
65.96
Today's Range
65.89 - 67.02
52wk Range
60.32 - 79.61
Shares Outstanding
1,300,260,832
Dividend Yield
3.36%
Performance
YTD
+4.70%
+4.70%
1 Month
+3.57%
+3.57%
3 Month
-4.27%
-4.27%
6 Month
+4.16%
+4.16%
1 Year
-11.24%
-11.24%
Top News
More News
Advances in Biotechnology May Offer Cancer Patients Renewed Hope
September 10, 2019
FinancialBuzz.com News Commentary
Read More
from
PR Newswire
Gilead Sciences and the Elton John AIDS Foundation Launch RADIAN Initiative to Address HIV in Eastern Europe and Central Asia (EECA)
September 09, 2019
Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation today announced the launch of the ground-breaking RADIAN initiative at the Fast-Track Cities 2019 conference in London. RADIAN...
Read More
from
Business Wire News Releases
More News
Read More
Value investing isn’t back — but economic growth is
September 19, 2019
category
BA
,
Pharmaceuticals
,
DJIA
, and 30 more.
from
MarketWatch
PBE, GILD, ALXN, INCY: Large Outflows Detected at ETF
September 17, 2019
category
ETFs
from
ETF Channel
Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences
Today 7:30 EDT
category
Market News
,
ICPT
,
GNFT
, and 2 more.
from
Motley Fool
Next Resistance Level for Gilead Sciences (GILD) is $66.44
September 19, 2019
from
Comtex SmarTrend® News Briefs
3 Biotechs With the Biggest Cash Stockpiles
September 20, 2019
category
BMY
,
Market News
,
GLPG
, and 4 more.
from
Motley Fool
Interesting GILD Put And Call Options For November 1st
September 12, 2019
category
Stocks
from
Market News Video
NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Revolutionary Gene Therapies to Fight Cancer
September 06, 2019
from
NetworkNewsWire
An Investor's Guide to Disrupting Drugmakers
September 18, 2019
category
SNY
,
ABBV
,
Market News
, and 3 more.
from
Motley Fool
Notable Wednesday Option Activity: AXDX, GILD, MDB
September 11, 2019
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
